Odonate Therapeutics, LLC IPO Research Information

Odonate Therapeutics, LLC IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Odonate Therapeutics, LLC, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Odonate Therapeutics, LLC	ODT - NASDAQ	$24.00-$27.00	$24.00	$23.00	6.25 million	12/7/2017
Underwriter(s): Goldman Sachs, Jefferies
Co-Manager(s): Cowen
Industry: Health Care
Filing(s): Filed 2017-11-13 Terms Added 2017-11-27 Final Prospectus 2017-12-08

Odonate Therapeutics, LLC Quote & Chart - Click for current quote - ODT

About Odonate Therapeutics, LLC (adapted from Odonate Therapeutics, LLC prospectus):
They are a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ODT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.